Free Trial

Price T Rowe Associates Inc. MD Has $12.83 Million Holdings in Cadre Holdings, Inc. (NYSE:CDRE)

Cadre logo with Industrials background

Price T Rowe Associates Inc. MD lowered its stake in shares of Cadre Holdings, Inc. (NYSE:CDRE - Free Report) by 13.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 397,183 shares of the company's stock after selling 63,143 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.98% of Cadre worth $12,830,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. US Bancorp DE boosted its stake in shares of Cadre by 10.6% in the 4th quarter. US Bancorp DE now owns 4,178 shares of the company's stock valued at $135,000 after purchasing an additional 400 shares during the last quarter. Truist Financial Corp boosted its stake in Cadre by 5.8% in the fourth quarter. Truist Financial Corp now owns 11,277 shares of the company's stock valued at $364,000 after acquiring an additional 616 shares during the last quarter. MetLife Investment Management LLC grew its holdings in Cadre by 6.0% during the 4th quarter. MetLife Investment Management LLC now owns 16,152 shares of the company's stock worth $522,000 after acquiring an additional 913 shares during the period. Assetmark Inc. bought a new stake in shares of Cadre during the 4th quarter valued at $31,000. Finally, Harel Insurance Investments & Financial Services Ltd. lifted its stake in shares of Cadre by 51.9% in the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,066 shares of the company's stock valued at $99,000 after purchasing an additional 1,048 shares during the period. 43.95% of the stock is owned by institutional investors.

Cadre Trading Up 2.1 %

NYSE CDRE traded up $0.73 during trading on Thursday, reaching $36.15. 58,048 shares of the stock traded hands, compared to its average volume of 249,931. Cadre Holdings, Inc. has a fifty-two week low of $27.07 and a fifty-two week high of $40.28. The stock's 50-day moving average price is $30.95 and its 200 day moving average price is $33.60. The firm has a market cap of $1.47 billion, a price-to-earnings ratio of 43.55, a price-to-earnings-growth ratio of 1.58 and a beta of 1.34. The company has a quick ratio of 1.96, a current ratio of 3.01 and a debt-to-equity ratio of 0.65.

Cadre (NYSE:CDRE - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.13 by $0.10. The firm had revenue of $130.11 million for the quarter, compared to analysts' expectations of $121.53 million. Cadre had a return on equity of 12.88% and a net margin of 6.34%. The business's quarterly revenue was down 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.18 EPS. Analysts predict that Cadre Holdings, Inc. will post 1.05 EPS for the current year.

Cadre Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 16th. Stockholders of record on Friday, May 2nd will be paid a dividend of $0.095 per share. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Friday, May 2nd. Cadre's dividend payout ratio is currently 42.22%.

Insider Activity

In other news, CEO Warren B. Kanders sold 50,000 shares of Cadre stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $31.88, for a total transaction of $1,594,000.00. Following the completion of the transaction, the chief executive officer now directly owns 10,866,192 shares in the company, valued at approximately $346,414,200.96. The trade was a 0.46 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 37.00% of the stock is currently owned by insiders.

Cadre Company Profile

(Free Report)

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.

See Also

Institutional Ownership by Quarter for Cadre (NYSE:CDRE)

Should You Invest $1,000 in Cadre Right Now?

Before you consider Cadre, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.

While Cadre currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines